|
Nov 16
|
AbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023
|
|
Nov 3
|
AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023
|
|
Nov 3
|
AbCellera Biologics Inc. (NASDAQ:ABCL) Q3 2023 Earnings Call Transcript
|
|
Nov 3
|
Q3 2023 Abcellera Biologics Inc Earnings Call
|
|
Nov 3
|
Prelude Therapeutics Inc (PRLD) Reports Q3 Financial Results and Strategic Pipeline Progress
|
|
Nov 3
|
AbCellera Biologics (ABCL) Q3 2023 Earnings Call Transcript
|
|
Nov 2
|
AbCellera Biologics Inc (ABCL) Reports Q3 2023 Earnings: Revenue Drops to $7 Million
|
|
Nov 2
|
AbCellera Reports Q3 2023 Business Results
|
|
Nov 1
|
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
|
|
Oct 31
|
AbCellera to Present at the Jefferies London Healthcare Conference on November 14, 2023
|
|
Apr 27
|
AbCellera Biologics Inc. (ABCL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Apr 24
|
7 Stocks Under $10 That Analysts Love
|
|
Mar 22
|
AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease
|